{
    "laboratory_examinations": [
        {
            "procedure_name": "Whole-exome sequencing",
            "date": "Not specified",
            "findings": "Novely heterozygous variants in ACAN identified in affected individuals; Family 1 had a frameshift mutation (c.272delA), Family 2 had a splice donor site variant (c.2026G>A), and Family 3 had a missense variant (c.7064T>C).",
            "changes_over_time": "Not specified."
        },
        {
            "procedure_name": "Bone age assessment",
            "date": "Chronologic age 5 years 2 months",
            "findings": "Bone age was markedly advanced at 9.0 years.",
            "changes_over_time": "His bone age has remained advanced approximately 4 years above chronologic age on repeat bone age assessments."
        },
        {
            "procedure_name": "Bone age assessment",
            "date": "At age 12 years 7 months",
            "findings": "Bone age was advanced at 14 years and 0 months.",
            "changes_over_time": "Not specified."
        },
        {
            "procedure_name": "Bone age assessment",
            "date": "At age 11 years and 7 months",
            "findings": "Bone age assessment revealed an advanced bone age of 13 years and 0 months.",
            "changes_over_time": "Repeat bone age assessments during GnRH analog treatment at chronologic age 12 years 5 months, and at 13 years 5 months were read as 13 years and 0 months, confirming that GnRH agonist treatment successfully blocked bone age advancement."
        }
    ]
}